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Our published homology model of KCNQ1(Biochemistry 46:14141;2007)
shows that four of the residues (S140, V141, I274, A300) associated with
gain-of-function mutations come together in the open state at the interface be-
tween the voltage sensor from one subunit and the pore domain of another.
We propose that the interaction between these residues enhances the open
state, yielding the higher activity measured when these KCNQ1 mutants are
co-expressed with KCNE1. To test this hypothesis KCNQ1 V141 and I274
residues were mutated to cysteine, expressed in CHO-K1 cells and whole-
cell currents measured from 80 to þ50mV, holding potential= 80mV.
Expression of KCNQ1_V141C-I274C channels generated whole-cell currents
much larger (615590 pA) than KCNQ1_WT (240564 pA) or either
KCNQ1_V141C (277526 pA) or KCNQ1_I274C (299560 pA) channels.
Analysis of biotinylated membrane proteins showed that KCNQ1_WT and
KCNQ1_V141C-I274C express at similar levels. To test whether the larger
currents measured from cells expressing KCNQ1_V141C-I274C channels
were due to V141C and I274C forming disulfide bonds; these cells were
superfused with DTT (reducing agent) or Cu/phenanthroline (disulfide-pro-
moting agent). DTT reduced current amplitude but not Cu-phenanthroline.
DTT likely reduces current magnitude by preventing disulfide bond formation,
while Cu-phenanthroline has no effect, presumably because all potential
V141C-I274C disulfide bonds are already formed. Further evidence that
KCNQ1 residues 141 and 274 interaction favors the open state was demon-
strated by superfusion of cells expressing KCNQ1_V141C-I274C channels
with a high potassium (Kþ) bath solution. A large inward current was
measured at negative potentials indicating that the channels were constitu-
tively open. Addition of DTT to the high Kþ bath reduced the inward current
amplitude. In summary, our results strongly suggest that the interaction be-
tween residues 141 and 274 in KCNQ1 favors the open state. In addition,
these results validate the KCNQ1 model as a viable tool for structure-
function relationship studies.
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Based on sequence homology, eight Shaker-related subfamilies of voltage-
gated Kþ (Kv) channel a-subunits have been identified: Kv1-Kv6 and
Kv8-Kv9. The Kv1-Kv4 subfamilies generate functional channels in both
homo- and heterotetrameric configuration while the silent (KvS) channel
subunits (Kv5-9) do not form functional homotetramers. These KvS subunits
assemble with Kv2 subunits generating functional Kv2/KvS heterotetramers
with unique biophysical properties. The diversity within the Kv2 subfamily
is further increased by interactions with auxiliary b-subunits (e.g. AMIGO
and KCNE1) resulting in altered biophysical properties compared to
Kv2.1 alone. While Kv2.1 subunits interact with both the modulatory KvS
a-subunits and auxiliary b-subunits, it has not been investigated whether
auxiliary b-subunits also interact with Kv2/KvS heterotetramers. We
demonstrate here that the transmembrane b-subunit KCNE1 also interacts
with Kv2.1/Kv6.4 heterotetramers. Co-expression of KCNE1 with Kv2.1
and Kv6.4 shifts the voltage-dependence of activation approximately 10
mV into hyperpolarizing potentials compared to that of Kv2.1/Kv6.4 alone,
without influencing the voltage-dependence of the Kv2.1/Kv6.4 inactivation.
This Kv2.1/Kv6.4/KCNE1 interaction was confirmed by Fluorescence Reso-
nance Energy Transfer (FRET) experiments. Co-expression of N-terminal
CFP-tagged Kv6.4 with C-terminal YFP-tagged KCNE1 in HEK293 cells
did not result in FRET while co-expression of CFP-Kv6.4 with KCNE1-
YFP and unlabeled Kv2.1 yielded a FRET efficiency of 6 % which is similar
to the FRET efficiency of the positive CFP-Kv2.1 þ KCNE1-YFP combina-
tion. Furthermore, RT-PCR experiments revealed that Kv6.4 and KCNE1
subunits posses an overlapping expression pattern. These results suggest
that a triple complex consisting of Kv2.1, Kv6.4 and KCNE1 subunits can
be formed in heterologous cells and might also exist and play a function
in vivo.
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Encoded by Kv7.2/Kv7.3 subunit assembly, M-channels generate sub-
threshold voltage-gated Kþ currents that regulate neuronal excitability. In
our quest to target neuronal M-channels, we previously designed novel
diphenylamine carboxylates that are powerful Kv7.2 channel openers. These
drugs stabilize the Kv7.2 channel open state by interacting with its voltage
sensing domain (VSD). Using the same structural framework, we designed a
novel molecule, NH34, to test its activity on neuronal excitability and probe
its potency in vivo on inflammatory and neuropathic pain. In transfected
CHO cells, NH34 significantly increased Kv7.2 currents, by producing a hyper-
polarizing voltage shift of the activation curve (EC50 = 17.5 mM). Interestingly,
two S4 mutants, R198A and R207W significantly decreased the opener potency
of the drug, suggesting that NH34, like NH29, may interact with the VSD of
Kv7.2. NH34 preferentially acts as an opener of Kv7.2 and Kv7.3 channels.
NH34 was ineffective on Kv7.4 and Kv7.5 but produced a significant inhibition
of TRPV1 cation channels. In CA1 pyramidal neurons from rat hippocampal
slices, NH34 reduced the spike discharge frequency evoked by injection of de-
polarizing current. NH34 significantly depressed the slope of field epsp and the
fiber volley amplitude recorded extracellularly in the CA1 pyramidal region
following stimulation of the Schaeffer collaterals. NH34 reduced the frequency
of evoked spike discharge in dorsal root ganglion neurons. In vivo, NH34
(3-30 mg/kg p.o) significantly relieved the hyperalgesia evoked by mechanical
pressure of the paw in a rat model of inflammatory pain. Similarly, NH34 (3-30
mg/kg p.o) was very efficient in alleviating the hyperalgesia evoked by
mechanical pressure or cold allodynia in a Seltzer rat model of neuropathic
pain. In all, the data suggest that NH34 is a very promising drug template for
treating inflammatory and neuropathic pain.
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KCNQ1 associates with KCNE1 (Q1/E1) to form slow delayed rectifier (IKs)
channels, a ‘repolarization reserve’ in human ventricles. IKs activators may be
used to treat LQT syndromes. The level of E1 presence in Q1/E1 complexes
can affect the potency of IKs activators and their therapeutic efficacy. We inves-
tigate the molecular mechanisms of ‘E1-induced change in potency’ for two
experimental IKs activators: thimerosal (TMS) and ML277. TMS acts from
outside the cell membrane and requires disulfide formation with native Cys to
manifest its activator effect. TMS left shifts the half-maximum activation
voltage (V0.5) of both Q1 and Q1/E1. In oocyte expression, TMS increases the
estimated maximal current amplitude (Imax) of Q1/E1 but reduces Imax of Q1.
ML277 acts from inside the cell membrane. ML277 left shifts V0.5 and increases
Imax, with a higher potency in Q1 than Q1/E1. We identify two putative ‘drug-
binding pockets’ in our experimentally validated 3-D models of Q1 and Q1/E1:
one in the space between S3 and S4 helices accessible to the extracellular space
and right above C214 on S3, and the other between S2-S3 and S4-S5 linkers
accessible to the intracellular space. They are defined as putative TMS- and
ML277-binding sites, respectively. In silico docking shows: (a) TMS salt-
bridges with K218 when docked to Q1, but salt-bridges with R228 when docked
to Q1/E1. (b)ML277 preferentially interacts with a ring of Arg on S2-S3 and S4-
S5 linkers when docked to Q1, but aromatic stacks with a ring of Phe on S5 and
S6 when docked to Q1/E1. Mutagenesis/voltage-clamp experiments are under-
way to test these predictions, and implications in drug potency are interpreted
based on our knowledge of the structure-function relationship of IKs channel.
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Calmodulin (CaM) confers calcium-dependent regulation to a large array of
intracellular proteins, although calcium independent functions have also
142a Sunday, February 16, 2014been described. In KCNQ/Kv7 channels, the molecular determinants of the
M-current, a slow voltage-dependent non-inactivating neuronal potassium-
selective current, CaM binding is essential for channel trafficking to the
plasma membrane. The goal of the present work is to investigate whether
changes in the availability of CaM could influence membrane expression of
Kv7.2 channels. To this end, different ratios of Kv7.2 and CaM cDNAs
have been used to transfect HEK-293T cells, and the expressed current den-
sity has been assessed by whole-cell patch-clamp. When Kv7.2 and CaM
were transfected at a 1:1 cDNA ratio, Kv7.2 current density was identical
to that recorded in control cells. By contrast, increasing the CaM/Kv7.2
cDNA ratio to 10:1 and 20:1 caused a dose-dependent increase in current den-
sity (by 50 and 90%, respectively). Similar increases in current densities were
observed when Kv7.2 cDNA was transfected at identical ratios with a mutant
CaM unable to bind calcium (CaM1234). These results suggest that the
amount of apo-CaM accessible to Kv7.2 is limiting for channel function,
raising the intriguing possibility that changes in CaM availability meditated
by binding partners (eg. neurogranin, neuromodulin), which are known to
occur during long term potentation (Zhong et al., EMBO J, 28:3027, 2009),
might rely on changes in M-current density.
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M-currents, encoded by Kv7.2/7.3 genes, are low-threshold, voltage-gated
potassium channels which contribute to resting membrane potential (Vm)
and regulate neuronal excitability. Here, we tested the hypothesis that the
development of mouse striatal neurons is associated with enhanced expres-
sion and activity of M-currents and that determined whether forced expres-
sion of Kv7.2/7.3 accelerates the functional maturation of neurons
differentiating from human induced pluripotent stem (iPS) cells. Neurons
from the developing mouse striatum were isolated at E13, E15 and E17
and cultured in vitro for up to 14 days; functional profiles of the neurons
were explored using whole-cell patch-clamp. In some experiments, subven-
tricular and mantle zones were separated by laser microdissection and chan-
nel subunit ontogenies determined by gene chip array. Shortly after isolation
(1 day in vitro), there was a clear in vivo development-dependent hyperpo-
larisation of Vm (E13=-24.852.3 mV (n=26), E15=-40.052.2 mV (n=12),
E17=-47.252.4 mV (n=9)). Although Vm continued to hyperpolarise in
vitro, by 7 days these differences has disappeared (e.g. E13=-52.152.8
mV (n=8), E17 =-54.751.9 (n=5)). Associated with these observations,
were parallel and progressive increases in M-current activity during in
vivo and in vitro development, as evidenced by more pronounced responses
to retigabine and XE991. Further, both Kv7.2 and 7.3 genes were progres-
sively enriched in the mantle zone during in vivo development. Importantly,
human iPS cell-derived neurons nucleofected with a concatenated Kv7.2/7.3
cDNA plasmid demonstrated a significantly hyperpolarized Vm (from
39.952.2 mV (n=12) to 51.351.1 mV (n=11)) and a dramatic increase
in the proportion of cells generating action potentials spontaneously. Taken
together, these data indicate that development of striatal neurons is associ-
ated with increased M-current expression and that this might be causative
as suggested by the effect of forced Kv7.2/7.3 expression in the iPS cell-
derived neurons.
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KCNQ genes encode five Kv7 Kþ channel subunits (Kv7.1-Kv7.5). Four of
these (Kv7.2-Kv7.5) are expressed in the nervous system. Kv7.2 and Kv7.3are the principal molecular components of the slow voltage-gated M-chan-
nel, which regulates neuronal excitability. In this study, we demonstrate that
tamoxifen, an estrogen receptor antagonist used in the treatment of breast
cancer, inhibits Kv7.2/Kv7.3 currents heterologously expressed in human
embryonic kidney HEK-293 cells. Current inhibition by tamoxifen was
voltage independent but concentration-dependent. The IC50 for current in-
hibition was 1.68 5 0.44 mM. The voltage-dependent activation of the
channel was not modified. Tamoxifen inhibited Kv7.2 homomeric channels
with a higher potency (IC50 = 0.74 5 0.16 mM). The mutation Kv7.2
R463E increases phosphatidylinositol- 4,5-bisphosphate (PIP2) - channel
interaction and diminished dramatically the inhibitory effect of tamoxifen
compared with that for wild type Kv7.2. Conversely, the mutation Kv7.2
R463Q, which decreases PIP2 -channel interaction, increased tamoxifen po-
tency. Similar results were obtained on the heteromeric Kv7.2 R463Q/
Kv7.3 and Kv7.2 R463E/Kv7.3 channels, compared to Kv7.2/Kv7.3 WT.
Overexpression of type 2A PI(4)P5-kinase (PIP5K 2A) significantly
reduced tamoxifen inhibition of Kv7.2/Kv7.3 and Kv7.2 R463Q channels.
Our results suggest that tamoxifen inhibited Kv7.2/Kv7.3 channels by inter-
fering with PIP2-channel interaction because of its documented interaction
with PIP2 and the similar effect of tamoxifen on various PIP2 sensitive
channels.
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The IKs channel is a slowly activating potassium channel that generates one of
the potassium currents that limits the duration of the cardiac action potential.
The IKs channel consists of 4 pore forming alpha subunits (KCNQ1) and 2-4
beta subunits (KCNE1). The four KCNQ1 subunits form functional potassium
channels, but the KCNE1 beta subunit is necessary to recapitulate the slow
activation kinetics of the IKs channel. The mechanism by which KCNE1
slows the kinetics of KCNQ1 channels is a matter of current controversy.
Here, we use a combination of voltage clamp fluorometry (VCF) and gating
current measurements to show that IKs channel activation occurs in two steps:
(1) mutually independent voltage sensor movements in the four KCNQ1 sub-
units generate the main gating charge movement and underlie the delay in the
activation time course of the KCNQ1/KCNE1 currents, (2) a slower and
concerted conformational change of all four voltage sensors and the gate,
which opens the KCNQ1/KCNE1 channel. Gating currents develop with a
similar time and voltage dependence as the first fluorescence component, as
if the first component reports on the main S4 charge movement. In contrast
to other Kv channels, the voltage dependences of the main voltage sensor
movement and channel opening are separated by over 100 mV. The two acti-
vation steps in KCNQ1/KCNE1 channels can be farther separated by a
disease-causing mutation in KCNE1. We determine rates and voltage depen-
dence of the gating transitions to construct a model for KCNQ1/KCNE1 chan-
nels. Our model is consistent with that KCNQ1/KCNE1 channel has a fast S4
movement at negative voltages that moves the majority of gating charge and a
slower second conformational change at positive voltages that moves a
smaller amount of gating charge and opens the gate.
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The five KCNE b-subunits interact with several members of the Kv channels,
thereby modifying channel gating via the interaction of their single
transmembrane-spanning segment, the extracellular amino terminus, and/or
the intracellular carboxy terminus with the Kv a-subunit. Best studied is the
molecular basis of interactions between KCNE1 and Kv7.1, which, together,
supposedly form the native cardiac I(Ks) channel. Besides biophysical effects
the pharmacology of Kv7.1 is modulated by KCNE1. Kv7.1 is coexpressed
with different KCNEs in tissue specific combinations. Highly selective com-
ponds that can discriminate between Kv7.1/KCNEx-complexes may allow
for tissue specific action of drug candidates. Here, we present data on the first
highly potent, pure Kv7.1/KCNE1 inhibitor" that does not act on Kv7.1 alone.
We determine its binding site and interpret underlying structural mechanisms
of subtype selectivity.
